IVI Hosts 16th International Vaccinology Course in Seoul on September 26-30
- About 90 participants from 25 countries including trainees participate in this year’s course aimed at increasing developing country capacity in vaccines and vaccination
- Dr. Jean William Pape, leading AIDS and infectious disease expert from Haiti and winner of the Bill and Melinda Gates Global Health award, to give keynote speech on September 30
- More than 30 experts from international agencies, research institutions, universities, industry and non-profit organizations, including IVI, WHO and the U.S. NIH will serve as faculty members
September 26, 2016, Seoul, South Korea— The International Vaccine Institute (IVI), an international organization devoted to the development and introduction of new vaccines for global public health, convened the 16th International Vaccinology Course (IVC) at the IVI headquarters in Seoul from September 26 to 30.
The annual course aims to build capacity of vaccine professionals, especially from developing countries, in vaccinology from vaccine discovery to development to introduction in order to help increase developing country capacity in vaccines and vaccination. This year’s course brings together nearly 90 participants from 25 countries, including trainees and faculty from Korea, the U.S., India, the Philippines and Vietnam this year. The trainees include 10 students from developing countries such as Bangladesh, Madagascar and Pakistan who were awarded fellowships to attend the course. The fellowships were made possible due to support from Green Cross, Pfizer, Community Chest of Korea Incheon, Sky 72 Golf Club, Sanofi Pasteur and Janssen Pharmaceutical Companies of Johnson & Johnson.
Lectures by leading experts in vaccinology and interactive case studies cover topics that include epidemiology, vaccine design strategies, clinical development, ethics, regulatory assessment of vaccines, financing, vaccine communications, safety and vaccine effectiveness. More than 30 experts from international agencies, including IVI and the World Health Organization; research institutions, including the U.S. National Institutes of Health; industry; universities; and non-profit organizations serve as faculty members.
Notably, Dr. Jean William Pape, professor of medicine at Cornell University in the U.S. and a champion of public health in developing countries, will give the closing keynote speech on September 30 to share his knowledge and decades-long experience. In 1982, Dr. Pape founded ‘GHESKIO’ in Haiti, which is currently one of the largest AIDS and Tuberculosis centers in the Americas. GHESKIO is providing free care to over 500,000 patients with HIV and related diseases annually, and its research has informed the treatment and care of AIDS patients in both developed and developed countries. Dr. Pape also successfully led the effort to cut in half the national infant mortality in Haiti. He has been recognized by many awards including the Bill and Melinda Gates Global Health Award, the Clinton Global Citizen Award, and the 2014 WHO Stop TB Kochon Award presented to GHESKIO for its contributions to global health and swift response to treat the sick and injured in the aftermath of the 2010 earthquake in Haiti.
The weeklong course entails several topical lectures including those on the Zika virus by Dr. Yoon In-kyu, IVI’s Deputy Director General for Science, MERS-CoV by Dr. Kayvon Modjarrad from Walter Reed Army Institute of Research in the U.S., and Hepatitis E by Dr. Laura Digilio, IVI’s Deputy Director General for Development and Delivery. Dr. Jee Youngmee, Director General of the Center for Pathology and Immunology from the Korea Centers for Disease Control & Prevention (KCDC) and an incoming member of WHO Strategic Advisory Group of Experts (SAGE) on Immunization will give closing remarks.
“While the world must speed up the development of vaccines against a number of infectious diseases including MERS, Zika and Ebola, we can also save lives by accelerating the use of existing and underutilized vaccines in the developing world,” IVI Director General Dr. Jerome Kim said. “IVI’s Vaccinology Course provides professionals, especially those from developing countries, the opportunities to obtain the latest information and practical knowledge and to share their experiences and views with each other. Information-sharing, connecting and collaborating are essential to help increase access to new and existing vaccines globally.”
The course is jointly sponsored by Pfizer, Green Cross Corp., Community Chest of Korea Incheon, Sky 72 Golf Club, Janssen Pharmaceutical Companies of Johnson & Johnson, Sanofi Pasteur, SK Chemicals, Eubiologics, Korea Support Committee for IVI (KSC), Wonbang Enterprises, Nonghyup Bank SNU Branch, Raphas, Taein, MICE Seoul / Seoul Metropolitan Government, and others. Core support comes from Republic of Korea and Sweden.
The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 30 countries of Asia, Africa and Latin America on vaccines against diarrheal infections, bacterial meningitis and pneumonia, as well as Japanese encephalitis and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea. For more information, please visit www.ivi.int.
Tae Kyung Byun
Senior Manager of Korean Communications, IVI
Phone: +82-2-872-2801 (Ext. 159)